ConductScience.org, home

Paper42406005

Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.

Ahuja S and 4 others. Ther Innov Regul Sci, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough. Papers, record 42406005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42406005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.
PubMed
Journal
Ther Innov Regul Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahuja SSapna
2Kanwar DDivya
3Silakari PPragati
4Sahu SKSanjeev Kumarhttps://orcid.org/0000-0002-5472-1976
5Kaur PParanjeethttps://orcid.org/0000-0002-8332-8057

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug RepositioningMajor topic
Chemistry, PharmaceuticalMajor topic
COVID-19 Drug TreatmentMajor topic
Humans
Structure-Activity Relationship
Drug Discovery
Precision Medicine

Source PubMed

Download CSV of topics

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132615525Repurposing old drugs to fight multidrug resistant cancers.Drug Resist Updat2020https://conductscience.org/library/papers/32615525PubMed
233190955Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments.Arch Med Res2021https://conductscience.org/library/papers/33190955PubMed
336477604DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features.Sci Rep2022https://conductscience.org/library/papers/36477604PubMed
434550729Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers.Sci Transl Med2021https://conductscience.org/library/papers/34550729PubMed
524239728Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.Drug Discov Today2014https://conductscience.org/library/papers/24239728PubMed
624901567Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.Nat Med2014https://conductscience.org/library/papers/24901567PubMed
732419905Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs.Comput Struct Biotechnol J2020https://conductscience.org/library/papers/32419905PubMed
837589736Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection?Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/37589736PubMed
932845283Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial.JAMA Cardiol2020https://conductscience.org/library/papers/32845283PubMed
1039457604Compared Antileishmanial Activity of Clomiphene and Tamoxifen.Biomedicines2024https://conductscience.org/library/papers/39457604PubMed
1131238113Drug repurposing: a promising tool to accelerate the drug discovery process.Drug Discov Today2019https://conductscience.org/library/papers/31238113PubMed
1233617254A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions.J Med Chem2021https://conductscience.org/library/papers/33617254PubMed
1330513339The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.Drug Discov Today2019https://conductscience.org/library/papers/30513339PubMed
1430310233Drug repurposing: progress, challenges and recommendations.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30310233PubMed
1535906687Drug repurposing: a systematic review on root causes, barriers and facilitators.BMC Health Serv Res2022https://conductscience.org/library/papers/35906687PubMed
1628369768Drug repurposing from the perspective of pharmaceutical companies.Br J Pharmacol2018https://conductscience.org/library/papers/28369768PubMed
1729874824Changing Trends in Computational Drug Repositioning.Pharmaceuticals (Basel)2018https://conductscience.org/library/papers/29874824PubMed
1830123072Review of Drug Repositioning Approaches and Resources.Int J Biol Sci2018https://conductscience.org/library/papers/30123072PubMed
1933431024A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions.J Cheminform2020https://conductscience.org/library/papers/33431024PubMed
2040608229Drug repurposing: a promising drug discovery strategy for the treatment of emerging epidemic infectious disease.Mol Divers2026https://conductscience.org/library/papers/40608229PubMed

See all 80 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42406005

GET https://conductscience.org/api/papers/v1/42406005/references?page=2